Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22 Vitamin D Deficiency 20 Prostatic Neoplasms 17 Polycystic Ovary Syndrome 9 Neoplasms 9 Colonic Neoplasms 8 Rectal Neoplasms 6 Colorectal Neoplasms 6 Osteoporosis 5 Myelodysplastic Syndromes 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Cardiovascular Diseases 4 Warts 3 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Brain Neoplasms 3 Adenomatous Polyps 3 Pathologic Processes 2 Pain 2 Obesity 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Musculoskeletal Diseases 2 Melanoma 2 Male Urogenital Diseases 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2

Interventions

Bupivacaine 2 Therapeutics 1 Sodium Chloride 1 Ralfinamide 1 Radiofrequency Ablation 1 Musculoskeletal Manipulations 1 Methylprednisolone 1 Lidoderm 1 Lidocaine 1 Indocyanine Green 1 Dry Needling 1 Decompression 1 Cryosurgery 1 Cholecalciferol 1 Botulinum Toxins, Type A 1 Bevacizumab 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuroma × Cholecalciferol × Clear all

NCT04115982 2021-08-31

D3NERV

University Hospital, Caen

Phase 3 Unknown

Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡